NirH is part of the nir gene cluster (nirSMCFDLGHJEN), which encodes proteins required for heme d₁ biosynthesis and nitrite reduction . The cluster includes:
NirS: Catalyzes nitrite reduction to nitric oxide (NO).
NirM, NirC, NirF: Involved in heme d₁ precursor formation.
NirD, NirL, NirG, NirH: Compose the siroheme decarboxylase complex, converting siroheme to 12,18-didecarboxy-siroheme, an intermediate in heme d₁ biosynthesis .
| Gene | Protein Function | Role in Heme d₁ Biosynthesis |
|---|---|---|
| nirS | Nitrite reductase | Reduces nitrite to NO |
| nirD, nirL, nirG, nirH | Siroheme decarboxylase | Removes carboxyl groups from siroheme |
| nirE | S-Adenosylmethionine-dependent methyltransferase | Methylates uroporphyrinogen III |
| nirN | Heme d₁ synthase | Introduces acrylic double bond to dihydro-heme d₁ |
| nirF | Unknown | Required for heme d₁ maturation |
NirH shares sequence homology with NirD (68.5% identity), NirL (60.4%), and NirG (63.9%) . These proteins form a decarboxylase complex that removes carboxyl groups from siroheme, a precursor of heme d₁.
Deletion of nirH (strain RM361) results in a complete loss of nitrite reductase (NirS) activity, as demonstrated by enzyme assays and heme staining . This confirms NirH’s indispensable role in heme d₁ biosynthesis.
| Strain (Genotype) | NirS Activity (mU/mg protein) | Heme d₁ Presence |
|---|---|---|
| PAO1 (wild type) | 48.3 | Yes |
| RM361 (nirH::tet) | Not Detected (ND) | No |
The pathway involves:
Uroporphyrinogen III methylation by NirE to form precorrin-2 .
Decarboxylation by NirD, NirL, NirG, and NirH to yield 12,18-didecarboxy-siroheme .
Final maturation by NirN, introducing a double bond to form heme d₁ .
NirH’s activity is tightly linked to NirD, NirL, and NirG. Mutations in any of these genes (e.g., nirD, nirL, nirG) also abolish NirS activity, highlighting the cooperative nature of the complex .
Denitrification allows P. aeruginosa to thrive in anaerobic environments, such as biofilms or host tissues. NirH’s role in this pathway underscores its potential as a therapeutic target to disrupt bacterial survival in infections .
Recombinant NirH could be used to study heme d₁ biosynthesis in vitro or engineer denitrification pathways in industrial microbes for bioremediation .
KEGG: pae:PA0512
STRING: 208964.PA0512
NirH is a critical component of the siroheme decarboxylase complex (NirD/NirL/NirG/NirH) responsible for converting siroheme to 12,18-didecarboxy-siroheme during heme d1 biosynthesis . This cofactor is essential for the nitrite reductase NirS, which drives denitrification.
Methodological considerations:
Pair UV-visible absorption spectroscopy and high-resolution mass spectrometry to confirm cofactor intermediates (e.g., dihydro-heme d1) .
Include 5-aminolevulinic acid in growth media to enhance heme precursor availability .
NirH participates in multi-protein complexes with denitrification enzymes. Key interaction data from affinity purification studies :
Combine co-purification assays with in vivo immunogold labeling to confirm spatial colocalization .
Use norB or nirS mutants to assess compensatory interactions in the protein network .
Discrepancies often arise from oxygen sensitivity or incomplete cofactor synthesis:
Anaerobic purification: Perform protein isolation in an oxygen-free chamber to preserve labile intermediates .
Cofactor reconstitution: Incubate apo-NirH with synthetic dihydro-heme d1 under reducing conditions .
Cross-validation: Compare resonance Raman spectroscopy (structural insights) with enzymatic activity assays (functional confirmation) .
Cryo-EM: Resolve large NirH-containing complexes (e.g., siroheme decarboxylase) at 3–4 Å resolution .
EPR spectroscopy: Characterize iron-sulfur clusters in NirH under varying redox states .
Molecular dynamics simulations: Model electron transfer pathways between NirH and NorB/NarH .